Kite Pharma

Kite Pharma Overview

Company Headquarters: California, US

Founded: 2009

Company Working:

Kite Pharma, a clinical-stage biopharmaceutical company that is focused on the development and commercialization of novel cancer immunotherapy products. The company has been developing a pipeline of engineered, autologous cell therapy-based product candidates for the treatment of solid and hematological malignancies. Its lead product candidate is KTE-C19, a CAR-based therapy is in Phase II of clinical trials. KTE-C19 is likely to aid in the treatment of patients with relapsed or refractory aggressive diffuse large B cell lymphoma, primary mediastinal B cell lymphoma, and transformed follicular lymphoma. The company has one operating segment, which primarily focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical need. The company operates as a cell therapy subsidiary of Gilead Sciences, Inc.

Strategy

Kite Pharma focuses on expanding its market in developing and underdeveloped regions by launching CAR T therapy products. Apart from this, the company is involved in developing innovative products for the treatment of cancer. Moreover, it is actively involved in strategic collaborations to increase its market penetration. The company also focuses on research to expand its product portfolio

Company Snapshot

$30,000M

Revenue

2009

Founded

California, US

Headquarters

SWOT Analysis

Strengths

Global presence
Skilled workforce
Strong R&D base
Strategic collaborations

Weaknesses

Product recalls in recent years

Opportunities

Expansions to untapped markets

Threats

Foreign currency exchange rate fluctuations

Product Offering

Kite Pharma
- CART T Therapy
- CAR Therapy Candidate

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.